Pharmacogenetic Testing Global Market Report 2025

Description

Pharmacogenetic testing is a specialized form of genetic testing that evaluates how an individual's genetic profile affects their response to specific medications, facilitating the customization of drug treatments to enhance efficacy and minimize side effects. This personalized approach significantly improves patient care by aligning therapies with genetic characteristics. It finds extensive application in areas such as oncology, psychology, and cardiology.

The primary types of pharmacogenetic testing include whole genome sequencing, whole exome sequencing, array-based tests, and single gene tests. Whole genome sequencing is a thorough method that analyzes the entire genome of an individual, sequencing all DNA in a single test to provide a comprehensive view of genetic information. The scope of drugs assessed includes prescription medications, nutraceuticals, recreational drugs, herbal supplements, vitamins, and over-the-counter products across various therapeutic areas, such as cardiology, gastroenterology, anesthesiology, genomics, endocrinology, immunology and hypersensitivity, dermatology, gynecology, oncology, and others. These products are distributed through hospital pharmacies, retail pharmacies, mail-order services, and direct-to-consumer channels, serving diverse end users including healthcare providers, pharmaceutical and biotechnology companies, research centers, and academic institutions.

The pharmacogenetic testing market research report is one of a series of new reports from The Business Research Company that provides pharmacogenetic testing market statistics, including pharmacogenetic testing industry global market size, regional shares, competitors with a pharmacogenetic testing market share, detailed pharmacogenetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacogenetic testing industry. This pharmacogenetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacogenetic testing market size has grown rapidly in recent years. It will grow from $12.37 billion in 2024 to $14.35 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increasing overall drug efficacy, increasing adoption of personalized medicine, growing need for precision diagnosis, increasing focus on pharmacogenetic testing, and increasing medical expenses.

The pharmacogenetic testing market size is expected to see rapid growth in the next few years. It will grow to $25.77 billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to rising research and development associated with biotechnology and healthcare, increasing healthcare expenditure, rising prevalence Of chronic diseases, increased accessibility, rise of telemedicine and digital health. Major trends in the forecast period include pharmacogenetic testing, advancements in genomic technologies, technological advancements, advances in companion diagnostics, and innovative diagnostic tests.

The rising demand for personalized medicine is anticipated to drive growth in the pharmacogenetic testing market in the foreseeable future. Also referred to as precision medicine, personalized medicine is a healthcare approach that customizes medical decisions and treatments to align with the individual characteristics of each patient. The growing focus on personalized medicine is influenced by multiple factors, including improved treatment outcomes, an emphasis on prevention and early detection, and enhanced cost-effectiveness. Pharmacogenetic testing plays a crucial role in personalized medicine by examining an individual's genetic makeup to predict their response to specific medications. This allows healthcare providers to customize treatments based on genetic factors, optimizing drug efficacy and minimizing adverse effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the escalating demand for personalized medicine is propelling the growth of the pharmacogenetic testing market.

Leading companies in the pharmacogenetics testing sector are advancing their offerings with cutting-edge pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to establish a competitive edge. Prescription-based pharmacogenetic testing involves genetic tests specifically ordered or prescribed by healthcare providers to analyze a patient's genetic profile prior to medication prescriptions. For example, in May 2023, UCSF, a US-based healthcare organization, introduced its pharmacogenomics testing service aimed at enhancing the precision of medical treatments. This service assists healthcare providers in tailoring drug therapies according to an individual's genetic profile, with the objective of improving drug efficacy, reducing adverse reactions, and bolstering personalized medicine strategies.

In May 2023, HealthOme, a US-based company specializing in advanced genetic testing and personalized medicine solutions, acquired Kailos Genetics for an undisclosed sum. This acquisition aims to strengthen HealthOme's genetic testing and personalized medicine capabilities by integrating Kailos Genetics' advanced genomic technologies and expertise. Kailos Genetics is a US-based firm that offers comprehensive pharmacogenetic testing services through its Inspexion platform.

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2023 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacogenetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacogenetic testing market consists of revenues earned by entities by providing services such as predicting drug efficacy, guiding dosage selection, and preventing adverse drug reactions. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmacogenetic testing market also includes sales of gene panels, deoxyribonucleic acid (DNA) sequencers, and home testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacogenetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmacogenetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacogenetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmacogenetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Whole Genome Sequencing; Whole Exome Sequencing; Array-Based Tests; Single Gene Tests
2) By Drug Type: Prescription Drugs; Nutraceuticals; Recreational Drugs; Herbal Supplements; Vitamins; Over-The-Counter Medications
3) By Therapeutic Area: Cardiology; Gastroenterology; Anesthesiology; Genomics; Endocrinology; Immunology And Hypersensitivity; Dermatology; Gynecology; Oncology; Other Therapeutic Areas
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacies; Mail-Order Pharmacies; Direct-to-Customer Services
5) By End User: Healthcare Providers; Pharmaceutical And Biotechnology Companies; Centers And Academic Institutes; Other End Users
Subsegments:
1) By Whole Genome Sequencing: Illumina Sequencing; Ion Torrent Sequencing; Pacific Biosciences Sequencing; Oxford Nanopore Sequencing
2) By Whole Exome Sequencing: Capture-Based Exome Sequencing; Targeted Enrichment Exome Sequencing; Hybridization-Based Exome Sequencing
3) By Array-Based Tests: SNP Array Testing; Expression Array Testing; Copy Number Variation Array Testing
4) By Single Gene Tests: Targeted Gene Panels; Mutation Detection Tests; Sequencing Of Specific Genes
Companies Mentioned: CVS Health Corporation; Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; Eurofins Scientific Inc.; Bio-Rad Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32144

1. Executive Summary

2. Pharmacogenetic Testing Market Characteristics

3. Pharmacogenetic Testing Market Trends And Strategies

4. Pharmacogenetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmacogenetic Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Pharmacogenetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Pharmacogenetic Testing Market Growth Rate Analysis
5.4. Global Pharmacogenetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Pharmacogenetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Pharmacogenetic Testing Total Addressable Market (TAM)

6. Pharmacogenetic Testing Market Segmentation

6.1. Global Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Genome Sequencing
Whole Exome Sequencing
Array-Based Tests
Single Gene Tests
6.2. Global Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Drugs
Nutraceuticals
Recreational Drugs
Herbal Supplements
Vitamins
Over-The-Counter Medications
6.3. Global Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiology
Gastroenterology
Anesthesiology
Genomics
Endocrinology
Immunology And Hypersensitivity
Dermatology
Gynecology
Oncology
Other Therapeutic Areas
6.4. Global Pharmacogenetic Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacies
Mail-Order Pharmacies
Direct-to-Customer Services
6.5. Global Pharmacogenetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Healthcare Providers
Pharmaceutical And Biotechnology Companies
Centers And Academic Institutes
Other End Users
6.6. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Illumina Sequencing
Ion Torrent Sequencing
Pacific Biosciences Sequencing
Oxford Nanopore Sequencing
6.7. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Capture-Based Exome Sequencing
Targeted Enrichment Exome Sequencing
Hybridization-Based Exome Sequencing
6.8. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Array-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
SNP Array Testing
Expression Array Testing
Copy Number Variation Array Testing
6.9. Global Pharmacogenetic Testing Market, Sub-Segmentation Of Single Gene Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Gene Panels
Mutation Detection Tests
Sequencing Of Specific Genes

7. Pharmacogenetic Testing Market Regional And Country Analysis

7.1. Global Pharmacogenetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Pharmacogenetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmacogenetic Testing Market

8.1. Asia-Pacific Pharmacogenetic Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmacogenetic Testing Market

9.1. China Pharmacogenetic Testing Market Overview
9.2. China Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmacogenetic Testing Market

10.1. India Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmacogenetic Testing Market

11.1. Japan Pharmacogenetic Testing Market Overview
11.2. Japan Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmacogenetic Testing Market

12.1. Australia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmacogenetic Testing Market

13.1. Indonesia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmacogenetic Testing Market

14.1. South Korea Pharmacogenetic Testing Market Overview
14.2. South Korea Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmacogenetic Testing Market

15.1. Western Europe Pharmacogenetic Testing Market Overview
15.2. Western Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmacogenetic Testing Market

16.1. UK Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmacogenetic Testing Market

17.1. Germany Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmacogenetic Testing Market

18.1. France Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmacogenetic Testing Market

19.1. Italy Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmacogenetic Testing Market

20.1. Spain Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmacogenetic Testing Market

21.1. Eastern Europe Pharmacogenetic Testing Market Overview
21.2. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmacogenetic Testing Market

22.1. Russia Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmacogenetic Testing Market

23.1. North America Pharmacogenetic Testing Market Overview
23.2. North America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmacogenetic Testing Market

24.1. USA Pharmacogenetic Testing Market Overview
24.2. USA Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmacogenetic Testing Market

25.1. Canada Pharmacogenetic Testing Market Overview
25.2. Canada Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmacogenetic Testing Market

26.1. South America Pharmacogenetic Testing Market Overview
26.2. South America Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmacogenetic Testing Market

27.1. Brazil Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmacogenetic Testing Market

28.1. Middle East Pharmacogenetic Testing Market Overview
28.2. Middle East Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmacogenetic Testing Market

29.1. Africa Pharmacogenetic Testing Market Overview
29.2. Africa Pharmacogenetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Pharmacogenetic Testing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Pharmacogenetic Testing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmacogenetic Testing Market Competitive Landscape And Company Profiles

30.1. Pharmacogenetic Testing Market Competitive Landscape
30.2. Pharmacogenetic Testing Market Company Profiles
- 30.2.1. CVS Health Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eurofins Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bio-Rad Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Pharmacogenetic Testing Market Other Major And Innovative Companies

31.1. Precision Medicine Advisors
31.2. Azenta Life Sciences
31.3. Fulgent Genetics
31.4. Pacific Biosciences of California Inc.
31.5. Castle Biosciences
31.6. 23andMe Holding Co.
31.7. Helix Inc.
31.8. Genomind Inc.
31.9. MD Labs
31.10. Sonic Genetics
31.11. AutoGenomics Inc.
31.12. LabClinics SA
31.13. Gene By Gene Ltd.
31.14. Xcode Life Sciences
31.15. YouScript

32. Global Pharmacogenetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmacogenetic Testing Market

34. Recent Developments In The Pharmacogenetic Testing Market

35. Pharmacogenetic Testing Market High Potential Countries, Segments and Strategies

35.1 Pharmacogenetic Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Pharmacogenetic Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Pharmacogenetic Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer